...
首页> 外文期刊>International Journal of Pharmaceutics >Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations
【24h】

Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations

机译:制剂和工艺变量对茶碱在控释制剂中的固态稳定性的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Understanding the impact of pharmaceutical processing, formulation excipients and their interactions on the solid-state transitions of pharmaceutical solids during use and in storage is critical in ensuring consistent product performance. This study reports the effect of polymer viscosity, diluent type, granulation and granulating fluid (water and isopropanol) on the pseudopolymorphic transition of theophylline anhydrous (THA) in controlled release formulations as well as the implications of this transition on critical quality attributes of the tablets. Accordingly, 12 formulations were prepared using a full factorial screening design and monitored over a 3 month period at 40 degrees C and 75%. Physicochemical characterization revealed a drastic drop in tablet hardness accompanied by a very significant increase in moisture content and swelling of all formulations. Spectroscopic analysis (ssNMR, Raman, NIR and PXRD) indicated conversion of THA to theophylline monohydrate (TMO) in all formulations prepared by aqueous wet granulation in as early as two weeks. Although all freshly prepared formulations contained THA, the hydration-dehydration process induced during aqueous wet granulation hastened the pseudopolymorphic conversion of theophylline during storage through a cascade of events. On the other hand, no solid state transformation was observed in directly compressed formulations and formulations in which isopropanol was employed as a granulating fluid even after the twelve weeks study period. The transition of THA to TMO resulted in a decrease in dissolution while an increase in dissolution was observed in directly compressed and IPA granulated formulation. Consequently, the impact of pseudopolymorphic transition of theophylline on dissolution in controlled release formulations may be the net result of two opposing factors: swelling and softening of the tablets which tend to favor an increase in drug dissolution and hydration of theophylline which decreases the drug dissolution. Published by Elsevier B.V.
机译:了解药物加工,制剂赋形剂及其相互作用对药物固体在使用和储存过程中的固态转化的影响,对于确保产品性能稳定至关重要。这项研究报告了聚合物粘度,稀释剂类型,制粒和制粒液(水和异丙醇)对茶碱无水(THA)在控释制剂中假多晶型转变的影响,以及这种转变对片剂关键质量属性的影响。因此,使用全因子筛选设计制备了12种制剂,并在40℃和75%的3个月内进行了监测。物化特性显示片剂硬度急剧下降,同时所有制剂的水分含量和溶胀度都显着增加。光谱分析(ssNMR,Raman,NIR和PXRD)表明,在通过水性湿法制粒制备的所有制剂中,THA均可在两周内转化为茶碱一水合物(TMO)。尽管所有新鲜制备的制剂均含有THA,但在水性湿法制粒过程中诱导的水合脱水过程通过一系列事件加速了茶碱的假多晶型转化。另一方面,即使在十二周研究期之后,在直接压缩的制剂和使用异丙醇作为制粒液的制剂中也未观察到固态转变。 THA向TMO的过渡导致溶解度降低,而在直接压制和IPA颗粒制剂中观察到溶解度增加。因此,茶碱假多晶型转变对控释制剂中溶出度的影响可能是两个相反因素的净结果:片剂的溶胀和软化,倾向于促进药物溶出度的增加和茶碱的水合作用,从而降低了药物的溶出度。由Elsevier B.V.发布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号